Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
8.07
-0.25 (-3.00%)
At close: Mar 24, 2026, 4:00 PM EDT
8.23
+0.16 (1.98%)
After-hours: Mar 24, 2026, 6:17 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Discovery and Development of Precision Medicines | 67.48M | 53.88M | - | - | - | | | | | |
Discovery and Development of Precision Medicines Growth | 25.24% | - | - | - | - | | | | | |
| 67.48M | 53.88M | - | - | - | | | | | |
| 25.24% | - | - | - | - | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 67.48M | 53.88M | - | - | - | | | | | |
| 25.24% | - | - | - | - | | | | | |
| 67.48M | 53.88M | - | - | - | | | | | |
| 25.24% | - | - | - | - | | | | | |
Source: S&P Global Market Intelligence.
